Europe Opioids Drug Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Opioids Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Opioids Drug Market Segmentations:

    By Player:

    • J&J

    • Egalet

    • Pernix

    • Endo

    • Mallinckrodt

    • Teva

    • Purdue Pharma

    • Hikma

    • INSYS

    • Pfizer

    • Mylan

    • Depomed

    • Vistapharm

    By Type:

    • Oxycodone

    • Hydromorphone

    • Codeine

    • Fentanyl

    • Others

    By End-User:

    • Pain Relief

    • Anesthesia

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Opioids Drug Market Size and Growth Rate of Oxycodone from 2014 to 2026

    • 1.3.2 Europe Opioids Drug Market Size and Growth Rate of Hydromorphone from 2014 to 2026

    • 1.3.3 Europe Opioids Drug Market Size and Growth Rate of Codeine from 2014 to 2026

    • 1.3.4 Europe Opioids Drug Market Size and Growth Rate of Fentanyl from 2014 to 2026

    • 1.3.5 Europe Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Opioids Drug Market Size and Growth Rate of Pain Relief from 2014 to 2026

    • 1.4.2 Europe Opioids Drug Market Size and Growth Rate of Anesthesia from 2014 to 2026

    • 1.4.3 Europe Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioids Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioids Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Oxycodone

      • 3.4.2 Market Size and Growth Rate of Hydromorphone

      • 3.4.3 Market Size and Growth Rate of Codeine

      • 3.4.4 Market Size and Growth Rate of Fentanyl

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Opioids Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioids Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pain Relief for Construction

      • 4.4.2 Market Size and Growth Rate of Anesthesia for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Opioids Drug Production Analysis by Top Regions

    • 5.2 Europe Opioids Drug Consumption Analysis by Top Regions

    • 5.3 Europe Opioids Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Opioids Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Opioids Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Opioids Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Opioids Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioids Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Opioids Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Opioids Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Opioids Drug Landscape Analysis

    • 7.1 Germany Opioids Drug Landscape Analysis by Major Types

    • 7.2 Germany Opioids Drug Landscape Analysis by Major End-Users

    8. UK Opioids Drug Landscape Analysis

    • 8.1 UK Opioids Drug Landscape Analysis by Major Types

    • 8.2 UK Opioids Drug Landscape Analysis by Major End-Users

    9. France Opioids Drug Landscape Analysis

    • 9.1 France Opioids Drug Landscape Analysis by Major Types

    • 9.2 France Opioids Drug Landscape Analysis by Major End-Users

    10. Italy Opioids Drug Landscape Analysis

    • 10.1 Italy Opioids Drug Landscape Analysis by Major Types

    • 10.2 Italy Opioids Drug Landscape Analysis by Major End-Users

    11. Spain Opioids Drug Landscape Analysis

    • 11.1 Spain Opioids Drug Landscape Analysis by Major Types

    • 11.2 Spain Opioids Drug Landscape Analysis by Major End-Users

    12. Poland Opioids Drug Landscape Analysis

    • 12.1 Poland Opioids Drug Landscape Analysis by Major Types

    • 12.2 Poland Opioids Drug Landscape Analysis by Major End-Users

    13. Russia Opioids Drug Landscape Analysis

    • 13.1 Russia Opioids Drug Landscape Analysis by Major Types

    • 13.2 Russia Opioids Drug Landscape Analysis by Major End-Users

    14. Switzerland Opioids Drug Landscape Analysis

    • 14.1 Switzerland Opioids Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Opioids Drug Landscape Analysis by Major End-Users

    15. Turkey Opioids Drug Landscape Analysis

    • 15.1 Turkey Opioids Drug Landscape Analysis by Major Types

    • 15.2 Turkey Opioids Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Opioids Drug Market Volume and Growth Rate

      • 16.3.2 Finland Opioids Drug Market Volume and Growth Rate

      • 16.3.3 Norway Opioids Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Opioids Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Opioids Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Opioids Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Opioids Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Opioids Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Opioids Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Opioids Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Opioids Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 J&J

      • 19.1.1 J&J Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Egalet

      • 19.2.1 Egalet Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Pernix

      • 19.3.1 Pernix Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Endo

      • 19.4.1 Endo Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Mallinckrodt

      • 19.5.1 Mallinckrodt Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Teva

      • 19.6.1 Teva Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Purdue Pharma

      • 19.7.1 Purdue Pharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Hikma

      • 19.8.1 Hikma Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 INSYS

      • 19.9.1 INSYS Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Pfizer

      • 19.10.1 Pfizer Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Mylan

      • 19.11.1 Mylan Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Depomed

      • 19.12.1 Depomed Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Vistapharm

      • 19.13.1 Vistapharm Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 121 Figures and 161 Tables)

    • Figure Product Picture

    • Figure Opioids Drug Market Size and Growth Rate of Oxycodone Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Hydromorphone Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Codeine Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Fentanyl Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Pain Relief from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Anesthesia from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Opioids Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioids Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioids Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioids Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Opioids Drug by Different Types from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Oxycodone Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Hydromorphone Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Codeine Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Fentanyl Market, 2015 - 2026 (USD Million)

    • Figure Opioids Drug Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioids Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioids Drug by Different End-Users from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Pain Relief from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Anesthesia from 2014 to 2026

    • Figure Opioids Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Opioids Drug Production by Major Regions

    • Table Europe Opioids Drug Production Share by Major Regions

    • Figure Europe Opioids Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Opioids Drug Consumption by Major Regions

    • Table Europe Opioids Drug Consumption Share by Major Regions

    • Table Germany Opioids Drug Production, Import, Consumption and Export Analysis

    • Table UK Opioids Drug Production, Import, Consumption and Export Analysis

    • Table France Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Italy Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Spain Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Poland Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Russia Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioids Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioids Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioids Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioids Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Opioids Drug Consumption by Types from 2014 to 2026

    • Table Germany Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Opioids Drug Consumption by Types from 2014 to 2026

    • Table UK Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table UK Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table UK Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Opioids Drug Consumption by Types from 2014 to 2026

    • Table France Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table France Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table France Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Opioids Drug Consumption by Types from 2014 to 2026

    • Table Italy Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Opioids Drug Consumption by Types from 2014 to 2026

    • Table Spain Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Opioids Drug Consumption by Types from 2014 to 2026

    • Table Poland Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Opioids Drug Consumption by Types from 2014 to 2026

    • Table Russia Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Opioids Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Opioids Drug Consumption by Types from 2014 to 2026

    • Table Turkey Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Opioids Drug Market Volume and Growth Rate from 2014 to 2026

    • Table J&J Profiles

    • Table J&J Production, Value, Price, Gross Margin 2014-2019

    • Table J&J Product benchmarking

    • Table J&J Strategic initiatives

    • Table J&J SWOT analysis

    • Table Egalet Profiles

    • Table Egalet Production, Value, Price, Gross Margin 2014-2019

    • Table Egalet Product benchmarking

    • Table Egalet Strategic initiatives

    • Table Egalet SWOT analysis

    • Table Pernix Profiles

    • Table Pernix Production, Value, Price, Gross Margin 2014-2019

    • Table Pernix Product benchmarking

    • Table Pernix Strategic initiatives

    • Table Pernix SWOT analysis

    • Table Endo Profiles

    • Table Endo Production, Value, Price, Gross Margin 2014-2019

    • Table Endo Product benchmarking

    • Table Endo Strategic initiatives

    • Table Endo SWOT analysis

    • Table Mallinckrodt Profiles

    • Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019

    • Table Mallinckrodt Product benchmarking

    • Table Mallinckrodt Strategic initiatives

    • Table Mallinckrodt SWOT analysis

    • Table Teva Profiles

    • Table Teva Production, Value, Price, Gross Margin 2014-2019

    • Table Teva Product benchmarking

    • Table Teva Strategic initiatives

    • Table Teva SWOT analysis

    • Table Purdue Pharma Profiles

    • Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Purdue Pharma Product benchmarking

    • Table Purdue Pharma Strategic initiatives

    • Table Purdue Pharma SWOT analysis

    • Table Hikma Profiles

    • Table Hikma Production, Value, Price, Gross Margin 2014-2019

    • Table Hikma Product benchmarking

    • Table Hikma Strategic initiatives

    • Table Hikma SWOT analysis

    • Table INSYS Profiles

    • Table INSYS Production, Value, Price, Gross Margin 2014-2019

    • Table INSYS Product benchmarking

    • Table INSYS Strategic initiatives

    • Table INSYS SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Mylan Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Mylan Product benchmarking

    • Table Mylan Strategic initiatives

    • Table Mylan SWOT analysis

    • Table Depomed Profiles

    • Table Depomed Production, Value, Price, Gross Margin 2014-2019

    • Table Depomed Product benchmarking

    • Table Depomed Strategic initiatives

    • Table Depomed SWOT analysis

    • Table Vistapharm Profiles

    • Table Vistapharm Production, Value, Price, Gross Margin 2014-2019

    • Table Vistapharm Product benchmarking

    • Table Vistapharm Strategic initiatives

    • Table Vistapharm SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.